EMA Authorised: Ucedane (carglumic acid) — Eurocept International BV

View source ↗

Summary

The European Medicines Agency has authorised Ucedane (carglumic acid) by Eurocept International BV for the treatment of hyperammonemia due to amino acid metabol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperammonemia

Drugs mentioned

• Ucedane (carglumic acid)

Snippet

Status: Authorised. Therapeutic area: Hyperammonemia;Amino Acid Metabolism, Inborn Errors. MAH: Eurocept International BV. Decision date: 24/09/2024